The Who, Where, and How of Regulating AI
By Eliza Strickland,
IEEE Spectrum
| 06. 14. 2023
During the past year, perhaps the only thing that has advanced as quickly as artificial intelligence is worry about artificial intelligence.
In the near term, many fear that chatbots such as OpenAI’s ChatGPT will flood the world with toxic language and disinformation, that automated decision-making systems will discriminate against certain groups, and that the lack of transparency in many AI systems will keep problems hidden. There’s also the looming concern of job displacement as AI systems prove themselves capable of matching or surpassing human performance. And in the long term, some prominent AI researchers fear that the creation of AI systems that are more intelligent than humans could pose an existential risk to our species.
The technology’s rapid advancement has brought new urgency to efforts around the world to regulate AI systems. The European Union got started first, and this week, on 14 June, took a step forward when one of its institutions, the European Parliament, voted to advance the draft legislation known as the AI Act. But China’s rule-makers have been moving the quickest to turn proposals into real...
Related Articles
By Hannah Devlin, The Guardian | 05.14.2024
Photo by Kind and Curious from Unsplash
When Great Ormond Street hospital (Gosh) published the results of its gene therapy trial for “bubble baby” syndrome it was hailed as a medical breakthrough. The treatment had a more than 95% success...
By Victoria Bisset and Adela Suliman, The Washington Post | 05.09.2024
Photo by CDC from Unsplash
A baby girl born with profound genetic deafness can now hear unaided after receiving a “groundbreaking” gene therapy trial, Britain’s National Health Service said Thursday.
Opal Sandy, an 18-month-old from Oxfordshire, England, is the first...
By Carrie Arnold, Nature Biotechnology | 04.17.2024
Tome Biosciences came out of stealth mode on 12 December with a haul of over $200 million to develop the company’s gene editing platform. Tome’s first order of business was to snap up Replace Therapeutics to expand its toolkit to...
By Rob Stein, NPR | 04.24.2024
Lisa Pisano was lying in a hospital bed at NYU Langone Health, hooked up to beeping monitors and an array of tubes. Her surgical wounds were still healing, and she looked tired. But the 54-year-old New Jersey woman said she...